Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression

Jamie E. Craig; Xikun Han; Ayub Qassim; Mark Hassall; Jessica N. Cooke Bailey; Tyler G. Kinzy; Anthony P. Khawaja; Jiyuan An; Henry Marshall; Puya Gharahkhani; Robert P. Igo; Stuart L. Graham; Paul R. Healey; Jue-sheng Ong; Tiger Zhou; Owen Siggs; Matthew H. Law; Emmanuelle Souzeau; Bronwyn Ridge; Pirro G. Hysi; Kathryn P. Burdon; Richard A. Mills; John Landers; Jonathan B. Ruddle; Ashish Agar; Anna Galanopoulos; Andrew J. R. White; Colin E. Willoughby; Nicholas H. Andrew; Stephen Best; Andrea L. Vincent; Ivan Goldberg; Graham Radford-smith; Nicholas G. Martin; Grant W. Montgomery; Veronique Vitart; Rene Hoehn; Robert Wojciechowski; Jost B. Jonas; Tin Aung; Louis R. Pasquale; Angela Jane Cree; Sobha Sivaprasad; Neeru A. Vallabh; Ananth C. Viswanathan; Francesca Pasutto; Jonathan L. Haines; Caroline C. W. Klaver; Cornelia M. Van Duijn; Robert J. Casson; Paul J. Foster; Peng Tee Khaw; Christopher J. Hammond; David A. Mackey; Paul Mitchell; Andrew J. Lotery; Janey L. Wiggs; Alex W. Hewitt; Stuart Macgregor

doi:10.1038/s41588-019-0556-y

Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression

Jamie E. Craig, Xikun Han, Ayub Qassim, Mark Hassall, Jessica N. Cooke Bailey, Tyler G. Kinzy, Anthony P. Khawaja, Jiyuan An, Henry Marshall, Puya Gharahkhani, Robert P. Igo, Stuart L. Graham, Paul R. Healey, Jue-sheng Ong, Tiger Zhou, Owen Siggs, Matthew H. Law, Emmanuelle Souzeau, Bronwyn Ridge, Pirro G. HysiKathryn P. Burdon, Richard A. Mills, John Landers, Jonathan B. Ruddle, Ashish Agar, Anna Galanopoulos, Andrew J. R. White, Colin E. Willoughby, Nicholas H. Andrew, Stephen Best, Andrea L. Vincent, Ivan Goldberg, Graham Radford-smith, Nicholas G. Martin, Grant W. Montgomery, Veronique Vitart, Rene Hoehn, Robert Wojciechowski, Jost B. Jonas, Tin Aung, Louis R. Pasquale, Angela Jane Cree, Sobha Sivaprasad, Neeru A. Vallabh, Ananth C. Viswanathan, Francesca Pasutto, Jonathan L. Haines, Caroline C. W. Klaver, Cornelia M. Van Duijn, Robert J. Casson, Paul J. Foster, Peng Tee Khaw, Christopher J. Hammond, David A. Mackey, Paul Mitchell, Andrew J. Lotery, Janey L. Wiggs, Alex W. Hewitt, Stuart Macgregor

School of Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

104 Citations (Scopus)

59 Downloads (Pure)

Abstract

Glaucoma, a disease characterized by progressive optic nerve degeneration, can be prevented through timely diagnosis and treatment. We characterize optic nerve photographs of 67,040 UK Biobank participants and use a multitrait genetic model to identify risk loci for glaucoma. A glaucoma polygenic risk score (PRS) enables effective risk stratification in unselected glaucoma cases and modifies penetrance of the MYOC variant encoding p.Gln368Ter, the most common glaucoma-associated myocilin variant. In the unselected glaucoma population, individuals in the top PRS decile reach an absolute risk for glaucoma 10 years earlier than the bottom decile and are at 15-fold increased risk of developing advanced glaucoma (top 10% versus remaining 90%, odds ratio = 4.20). The PRS predicts glaucoma progression in prospectively monitored, early manifest glaucoma cases (P = 0.004) and surgical intervention in advanced disease (P = 3.6 × 10-6). This glaucoma PRS will facilitate the development of a personalized approach for earlier treatment of high-risk individuals, with less intensive monitoring and treatment being possible for lower-risk groups.

Original language	English
Pages (from-to)	160-166
Number of pages	7
Journal	Nature Genetics
Volume	52
Issue number	2
Early online date	20 Jan 2020
DOIs	https://doi.org/10.1038/s41588-019-0556-y
Publication status	Published (in print/issue) - 29 Feb 2020

Bibliographical note

Funding Information:
is supported by the University of Queensland Research Training Scholarship and Queensland Institute of Medical Research Berghofer PhD Top Up Scholarship. We thank D. Whiteman, R. Neale and C. Olson for providing access to the QSkin samples for use as controls as part of NHMRC grant no. 1063061. We thank S. Wood, J. Pearson and S. Gordon from the Queensland Institute of Medical Research Berghofer Research Institute for their support. The NEIGHBORHOOD consortium is supported by National Institutes of Health grant nos. P30 EY014104, R01 EY015473 and R01 EY022305.

Funding Information:
This work was conducted using the UK Biobank Resource (application no. 25331) and publicly available data from the IGGC. The UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and Northwest Regional Development Agency. It also had funding from the Welsh Assembly Government, British Heart Foundation and Diabetes UK. The eye and vision dataset has been developed with additional funding from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, Fight for Sight charity, Moorfields Eye Charity, Macular Society, International Glaucoma Association and Alcon Research Institute. This work was also supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (nos. 1107098, 1116360, 1116495, 1023911, 1150144, 1147571), the Ophthalmic Research Institute of Australia, the BrightFocus Foundation, the UK and Eire Glaucoma Society and charitable funds from the Royal Liverpool University Hospital. S.M., J.E.C., K.P.B., D.A.M. and A.W.H. are supported by NHMRC Fellowships (APP1154543, APP1154824, APP1059954, APP1154513, APP1103329). S.M. was supported by an Australian Research Council Future Fellowship (FT130101902). L.R.P. is supported by National Institutes of Health grant no. R01 EY015473. X.H.

Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41588-019-0556-y

Accepted ManuscriptAuthor Accepted Manuscript, 1.61 MB

Cite this

Craig, J. E., Han, X., Qassim, A., Hassall, M., Cooke Bailey, J. N., Kinzy, T. G., Khawaja, A. P., An, J., Marshall, H., Gharahkhani, P., Igo, R. P., Graham, S. L., Healey, P. R., Ong, J., Zhou, T., Siggs, O., Law, M. H., Souzeau, E., Ridge, B., ... Macgregor, S. (2020). Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression. Nature Genetics, 52(2), 160-166. https://doi.org/10.1038/s41588-019-0556-y

@article{9dc42cf440254e9eb40379c5bab319c2,

title = "Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression",

abstract = "Glaucoma, a disease characterized by progressive optic nerve degeneration, can be prevented through timely diagnosis and treatment. We characterize optic nerve photographs of 67,040 UK Biobank participants and use a multitrait genetic model to identify risk loci for glaucoma. A glaucoma polygenic risk score (PRS) enables effective risk stratification in unselected glaucoma cases and modifies penetrance of the MYOC variant encoding p.Gln368Ter, the most common glaucoma-associated myocilin variant. In the unselected glaucoma population, individuals in the top PRS decile reach an absolute risk for glaucoma 10 years earlier than the bottom decile and are at 15-fold increased risk of developing advanced glaucoma (top 10% versus remaining 90%, odds ratio = 4.20). The PRS predicts glaucoma progression in prospectively monitored, early manifest glaucoma cases (P = 0.004) and surgical intervention in advanced disease (P = 3.6 × 10-6). This glaucoma PRS will facilitate the development of a personalized approach for earlier treatment of high-risk individuals, with less intensive monitoring and treatment being possible for lower-risk groups.",

author = "Craig, {Jamie E.} and Xikun Han and Ayub Qassim and Mark Hassall and {Cooke Bailey}, {Jessica N.} and Kinzy, {Tyler G.} and Khawaja, {Anthony P.} and Jiyuan An and Henry Marshall and Puya Gharahkhani and Igo, {Robert P.} and Graham, {Stuart L.} and Healey, {Paul R.} and Jue-sheng Ong and Tiger Zhou and Owen Siggs and Law, {Matthew H.} and Emmanuelle Souzeau and Bronwyn Ridge and Hysi, {Pirro G.} and Burdon, {Kathryn P.} and Mills, {Richard A.} and John Landers and Ruddle, {Jonathan B.} and Ashish Agar and Anna Galanopoulos and White, {Andrew J. R.} and Willoughby, {Colin E.} and Andrew, {Nicholas H.} and Stephen Best and Vincent, {Andrea L.} and Ivan Goldberg and Graham Radford-smith and Martin, {Nicholas G.} and Montgomery, {Grant W.} and Veronique Vitart and Rene Hoehn and Robert Wojciechowski and Jonas, {Jost B.} and Tin Aung and Pasquale, {Louis R.} and Cree, {Angela Jane} and Sobha Sivaprasad and Vallabh, {Neeru A.} and Viswanathan, {Ananth C.} and Francesca Pasutto and Haines, {Jonathan L.} and Klaver, {Caroline C. W.} and {Van Duijn}, {Cornelia M.} and Casson, {Robert J.} and Foster, {Paul J.} and Khaw, {Peng Tee} and Hammond, {Christopher J.} and Mackey, {David A.} and Paul Mitchell and Lotery, {Andrew J.} and Wiggs, {Janey L.} and Hewitt, {Alex W.} and Stuart Macgregor",

note = "Funding Information: is supported by the University of Queensland Research Training Scholarship and Queensland Institute of Medical Research Berghofer PhD Top Up Scholarship. We thank D. Whiteman, R. Neale and C. Olson for providing access to the QSkin samples for use as controls as part of NHMRC grant no. 1063061. We thank S. Wood, J. Pearson and S. Gordon from the Queensland Institute of Medical Research Berghofer Research Institute for their support. The NEIGHBORHOOD consortium is supported by National Institutes of Health grant nos. P30 EY014104, R01 EY015473 and R01 EY022305. Funding Information: This work was conducted using the UK Biobank Resource (application no. 25331) and publicly available data from the IGGC. The UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and Northwest Regional Development Agency. It also had funding from the Welsh Assembly Government, British Heart Foundation and Diabetes UK. The eye and vision dataset has been developed with additional funding from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, Fight for Sight charity, Moorfields Eye Charity, Macular Society, International Glaucoma Association and Alcon Research Institute. This work was also supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (nos. 1107098, 1116360, 1116495, 1023911, 1150144, 1147571), the Ophthalmic Research Institute of Australia, the BrightFocus Foundation, the UK and Eire Glaucoma Society and charitable funds from the Royal Liverpool University Hospital. S.M., J.E.C., K.P.B., D.A.M. and A.W.H. are supported by NHMRC Fellowships (APP1154543, APP1154824, APP1059954, APP1154513, APP1103329). S.M. was supported by an Australian Research Council Future Fellowship (FT130101902). L.R.P. is supported by National Institutes of Health grant no. R01 EY015473. X.H. Publisher Copyright: {\textcopyright} 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2020",

month = feb,

day = "29",

doi = "10.1038/s41588-019-0556-y",

language = "English",

volume = "52",

pages = "160--166",

journal = "Nature Genetics",

issn = "1061-4036",

publisher = "Springer Nature",

number = "2",

}

Craig, JE, Han, X, Qassim, A, Hassall, M, Cooke Bailey, JN, Kinzy, TG, Khawaja, AP, An, J, Marshall, H, Gharahkhani, P, Igo, RP, Graham, SL, Healey, PR, Ong, J, Zhou, T, Siggs, O, Law, MH, Souzeau, E, Ridge, B, Hysi, PG, Burdon, KP, Mills, RA, Landers, J, Ruddle, JB, Agar, A, Galanopoulos, A, White, AJR, Willoughby, CE, Andrew, NH, Best, S, Vincent, AL, Goldberg, I, Radford-smith, G, Martin, NG, Montgomery, GW, Vitart, V, Hoehn, R, Wojciechowski, R, Jonas, JB, Aung, T, Pasquale, LR, Cree, AJ, Sivaprasad, S, Vallabh, NA, Viswanathan, AC, Pasutto, F, Haines, JL, Klaver, CCW, Van Duijn, CM, Casson, RJ, Foster, PJ, Khaw, PT, Hammond, CJ, Mackey, DA, Mitchell, P, Lotery, AJ, Wiggs, JL, Hewitt, AW & Macgregor, S 2020, 'Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression', Nature Genetics, vol. 52, no. 2, pp. 160-166. https://doi.org/10.1038/s41588-019-0556-y

TY - JOUR

T1 - Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression

AU - Craig, Jamie E.

AU - Han, Xikun

AU - Qassim, Ayub

AU - Hassall, Mark

AU - Cooke Bailey, Jessica N.

AU - Kinzy, Tyler G.

AU - Khawaja, Anthony P.

AU - An, Jiyuan

AU - Marshall, Henry

AU - Gharahkhani, Puya

AU - Igo, Robert P.

AU - Graham, Stuart L.

AU - Healey, Paul R.

AU - Ong, Jue-sheng

AU - Zhou, Tiger

AU - Siggs, Owen

AU - Law, Matthew H.

AU - Souzeau, Emmanuelle

AU - Ridge, Bronwyn

AU - Hysi, Pirro G.

AU - Burdon, Kathryn P.

AU - Mills, Richard A.

AU - Landers, John

AU - Ruddle, Jonathan B.

AU - Agar, Ashish

AU - Galanopoulos, Anna

AU - White, Andrew J. R.

AU - Willoughby, Colin E.

AU - Andrew, Nicholas H.

AU - Best, Stephen

AU - Vincent, Andrea L.

AU - Goldberg, Ivan

AU - Radford-smith, Graham

AU - Martin, Nicholas G.

AU - Montgomery, Grant W.

AU - Vitart, Veronique

AU - Hoehn, Rene

AU - Wojciechowski, Robert

AU - Jonas, Jost B.

AU - Aung, Tin

AU - Pasquale, Louis R.

AU - Cree, Angela Jane

AU - Sivaprasad, Sobha

AU - Vallabh, Neeru A.

AU - Viswanathan, Ananth C.

AU - Pasutto, Francesca

AU - Haines, Jonathan L.

AU - Klaver, Caroline C. W.

AU - Van Duijn, Cornelia M.

AU - Casson, Robert J.

AU - Foster, Paul J.

AU - Khaw, Peng Tee

AU - Hammond, Christopher J.

AU - Mackey, David A.

AU - Mitchell, Paul

AU - Lotery, Andrew J.

AU - Wiggs, Janey L.

AU - Hewitt, Alex W.

AU - Macgregor, Stuart

N1 - Funding Information: is supported by the University of Queensland Research Training Scholarship and Queensland Institute of Medical Research Berghofer PhD Top Up Scholarship. We thank D. Whiteman, R. Neale and C. Olson for providing access to the QSkin samples for use as controls as part of NHMRC grant no. 1063061. We thank S. Wood, J. Pearson and S. Gordon from the Queensland Institute of Medical Research Berghofer Research Institute for their support. The NEIGHBORHOOD consortium is supported by National Institutes of Health grant nos. P30 EY014104, R01 EY015473 and R01 EY022305. Funding Information: This work was conducted using the UK Biobank Resource (application no. 25331) and publicly available data from the IGGC. The UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and Northwest Regional Development Agency. It also had funding from the Welsh Assembly Government, British Heart Foundation and Diabetes UK. The eye and vision dataset has been developed with additional funding from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, Fight for Sight charity, Moorfields Eye Charity, Macular Society, International Glaucoma Association and Alcon Research Institute. This work was also supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (nos. 1107098, 1116360, 1116495, 1023911, 1150144, 1147571), the Ophthalmic Research Institute of Australia, the BrightFocus Foundation, the UK and Eire Glaucoma Society and charitable funds from the Royal Liverpool University Hospital. S.M., J.E.C., K.P.B., D.A.M. and A.W.H. are supported by NHMRC Fellowships (APP1154543, APP1154824, APP1059954, APP1154513, APP1103329). S.M. was supported by an Australian Research Council Future Fellowship (FT130101902). L.R.P. is supported by National Institutes of Health grant no. R01 EY015473. X.H. Publisher Copyright: © 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.

PY - 2020/2/29

Y1 - 2020/2/29

N2 - Glaucoma, a disease characterized by progressive optic nerve degeneration, can be prevented through timely diagnosis and treatment. We characterize optic nerve photographs of 67,040 UK Biobank participants and use a multitrait genetic model to identify risk loci for glaucoma. A glaucoma polygenic risk score (PRS) enables effective risk stratification in unselected glaucoma cases and modifies penetrance of the MYOC variant encoding p.Gln368Ter, the most common glaucoma-associated myocilin variant. In the unselected glaucoma population, individuals in the top PRS decile reach an absolute risk for glaucoma 10 years earlier than the bottom decile and are at 15-fold increased risk of developing advanced glaucoma (top 10% versus remaining 90%, odds ratio = 4.20). The PRS predicts glaucoma progression in prospectively monitored, early manifest glaucoma cases (P = 0.004) and surgical intervention in advanced disease (P = 3.6 × 10-6). This glaucoma PRS will facilitate the development of a personalized approach for earlier treatment of high-risk individuals, with less intensive monitoring and treatment being possible for lower-risk groups.

AB - Glaucoma, a disease characterized by progressive optic nerve degeneration, can be prevented through timely diagnosis and treatment. We characterize optic nerve photographs of 67,040 UK Biobank participants and use a multitrait genetic model to identify risk loci for glaucoma. A glaucoma polygenic risk score (PRS) enables effective risk stratification in unselected glaucoma cases and modifies penetrance of the MYOC variant encoding p.Gln368Ter, the most common glaucoma-associated myocilin variant. In the unselected glaucoma population, individuals in the top PRS decile reach an absolute risk for glaucoma 10 years earlier than the bottom decile and are at 15-fold increased risk of developing advanced glaucoma (top 10% versus remaining 90%, odds ratio = 4.20). The PRS predicts glaucoma progression in prospectively monitored, early manifest glaucoma cases (P = 0.004) and surgical intervention in advanced disease (P = 3.6 × 10-6). This glaucoma PRS will facilitate the development of a personalized approach for earlier treatment of high-risk individuals, with less intensive monitoring and treatment being possible for lower-risk groups.

UR - http://www.scopus.com/inward/record.url?scp=85078279003&partnerID=8YFLogxK

UR - http://www.nature.com/articles/s41588-019-0556-y

UR - https://pure.ulster.ac.uk/en/publications/multitrait-analysis-of-glaucoma-identifies-new-risk-loci-and-enab

U2 - 10.1038/s41588-019-0556-y

DO - 10.1038/s41588-019-0556-y

M3 - Article

C2 - 31959993

VL - 52

SP - 160

EP - 166

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 2

ER -

Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this